glutathione and triple negative breast cancer Frontiers A review of biological targets
A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports Oncology Letters
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



